2. Admittedly, none of the authorities below has satisfied itself with regard to the applicability of provisions of ...

NEW YORK, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...

1. In this intra-Court appeal by the writ petitioners is directed against the order dated 16th December, 2024 in W.P.A. 29358 of 2024 passed by the learned Single Bench declining to grant any interim ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of ...

Despite positive trends in Cannabis adoption, both IIPR and NLCP face significant risks due to regulatory uncertainties and ...